193 related articles for article (PubMed ID: 21389156)
1. The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B.
Ito K; Higami K; Masaki N; Sugiyama M; Mukaide M; Saito H; Aoki Y; Sato Y; Imamura M; Murata K; Nomura H; Hige S; Adachi H; Hino K; Yatsuhashi H; Orito E; Kani S; Tanaka Y; Mizokami M
J Clin Microbiol; 2011 May; 49(5):1853-60. PubMed ID: 21389156
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?
Garcia RF; Moreira S; de Araújo Ramos AL; Ferreira LE; de Mattos AA; Tovo CV; Nader LA; Ramos JA; Rondinelli E; de Jesus Dominici A; Garcia CE; de Souza Leite Pinho M; Brandão-Mello CE; Villela-Nogueira CA; de França PH
World J Gastroenterol; 2013 Nov; 19(42):7399-404. PubMed ID: 24259970
[TBL] [Abstract][Full Text] [Related]
3. IFNL4/IL-28B haplotype structure and its impact on susceptibility to hepatitis C virus and treatment response in the Japanese population.
Ochi H; Miki D; Hayes CN; Abe H; Hayashida Y; Kubo M; Chayama K
J Gen Virol; 2014 Jun; 95(Pt 6):1297-1306. PubMed ID: 24646752
[TBL] [Abstract][Full Text] [Related]
4. Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4.
Domagalski K; Pawłowska M; Tretyn A; Halota W; Pilarczyk M; Smukalska E; Linkowska K; Grzybowski T
Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):745-54. PubMed ID: 23314745
[TBL] [Abstract][Full Text] [Related]
5. IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients.
Rosso C; Abate ML; Ciancio A; Strona S; Caviglia GP; Olivero A; Touscoz GA; Rizzetto M; Pellicano R; Smedile A
World J Gastroenterol; 2014 Sep; 20(36):13146-52. PubMed ID: 25278709
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy.
Shaker OG; Sadik NA
J Gastroenterol Hepatol; 2012 Dec; 27(12):1842-9. PubMed ID: 23020144
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-28B polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis.
Shi KQ; Liu WY; Lin XF; Fan YC; Chen YP; Zheng MH
Gene; 2012 Oct; 507(1):27-35. PubMed ID: 22842190
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
9. Response to treatment in Brazilian patients with chronic hepatitis C is associated with a single-nucleotide polymorphism near the interleukin-28B gene.
Grandi T; da Silva CM; Amaral KM; Picon PD; Costi C; da Fré NN; Fiegenbaum M; Niel C; Rossetti ML
Mem Inst Oswaldo Cruz; 2013 Feb; 108(1):48-53. PubMed ID: 23440114
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients.
de Castellarnau M; Aparicio E; Parera M; Franco S; Tural C; Clotet B; Martínez MA
PLoS One; 2012; 7(2):e31016. PubMed ID: 22328925
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-28B genotypes determine response to pegylated-interferon plus ribavirin therapy in patients with hepatitis C virus infection.
Osaki R; Nishimura T; Shioya M; Takeuchi T; Okumura Y; Nakahara T; Bamba S; Nakajo S; Fujiyama Y; Andoh A
Mol Med Rep; 2012 Feb; 5(2):525-8. PubMed ID: 22052088
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.
Derbala M; Rizk NM; Al-Kaabi S; John A; Sharma M; El-dweik N; Yakoob R; Pasic F; Almohanadi M; Alejji K; Abdelmola A; Butt M
Virology; 2013 Sep; 444(1-2):292-300. PubMed ID: 23866096
[TBL] [Abstract][Full Text] [Related]
13. Development of new IL28B genotyping method using Invader Plus assay.
Kani S; Tanaka Y; Matsuura K; Watanabe T; Yatsuhashi H; Orito E; Inose K; Motojuku N; Wakimoto Y; Mizokami M
Microbiol Immunol; 2012 May; 56(5):318-23. PubMed ID: 22537149
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-28B polymorphisms and response of chronic hepatitis C patients from Indonesia to pegylated interferon/ribavirin treatment.
Juniastuti ; Wibowo BP; Wibawa ID; Utsumi T; Mustika S; Amin M; Wahyuni RM; Kurniawan H; Hendrayana A; Setiawan PB; Yamani LN; Soetjipto ; Yano Y; Hotta H; Hayashi Y; Lusida MI
J Clin Microbiol; 2014 Jun; 52(6):2193-5. PubMed ID: 24696021
[TBL] [Abstract][Full Text] [Related]
15. [Differential response to pegylated interferon plus ribavirin combination therapy in chronic hepatitis C and HIV/HCV co-infected patients].
Liu B; Cai WP; Hu FY; Xu M; Lan Y; Tang XP
Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):829-33. PubMed ID: 24331692
[TBL] [Abstract][Full Text] [Related]
16. No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients.
Heo NY; Lim YS; Lee W; Oh M; An J; Lee D; Shim JH; Kim KM; Lee HC; Lee YS; Suh DJ
Clin Mol Hepatol; 2014 Jun; 20(2):177-84. PubMed ID: 25032184
[TBL] [Abstract][Full Text] [Related]
17. Assessment of interleukin 28B genotype as a predictor of response to combined therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients.
Fathy MM; Abo Taleb ME; El Hawary MS; Nabih MI; Aref WM; Makhlouf MM
Cytokine; 2015 Aug; 74(2):268-72. PubMed ID: 26003758
[TBL] [Abstract][Full Text] [Related]
18. Is rs8099917 polymorphism of IL-28B gene a good predictor of response to therapy of HCV than rs12979860? An Egyptian study.
Shaker O; Rashad A; Abd El Aziz G; El Raziky M
Cell Biochem Biophys; 2015 Jan; 71(1):307-14. PubMed ID: 25115611
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin.
Lyoo K; Song MJ; Hur W; Choi JE; Hong SW; Kim CW; Bae SH; Choi JY; Choi SW; Shin EC; Yoon SK
J Clin Virol; 2011 Dec; 52(4):363-6. PubMed ID: 21907615
[TBL] [Abstract][Full Text] [Related]
20. Association of MRC-1 and IL-28B with the treatment outcome of hepatitis C: a case control study.
Peng CY; Chen TH; Lim YP; Tsai FJ; Lin WY; Liao WL; Wan L
BMC Gastroenterol; 2014 Jun; 14():113. PubMed ID: 24969847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
